Pouya A Ameli

Pouya A Ameli, MD, MS

Assistant Professor of Neurology and Neurosurgery, Division of Neurocritical Care; Faculty Director, Medi-Futures/Medi-Gators Shadowing/Mentorship Programs; Member, Sickbay Research Group; Member, UF Health Delirium Task Force; Edu. Chair, NCC Foundation

Business Phone: (352) 273-5550

About Pouya A Ameli

Dr. Ameli is a neurointensivist with board certifications in neurology as well as neurocritical care. He received his medical degree from the University of Central Florida, where he received scholarship support in exchange for being among a selected group of students helping to launch UCF’s college of medicine. He then completed prestigious residency and fellowship training programs at Vanderbilt and Emory Universities. He was elected to the trainee section leadership for the Neurocritical Care Society (NCS) as a resident and picked to participate in the NCS Future Leaders’ Forum in 2018, maintaining various leadership roles in NCS since that time. He is currently the chair of the education committee for the Neurocritical Care Foundation, the philanthropy arm of NCS. He is also a member of the Society for Critical Care Medicine, the American Academy of Neurology, and the American Heart/Stroke Association.

Dr. Ameli has participated in a variety of basic science and clinical research projects, ranging from the role of specific cell cycle kinases in the development of prostate and breast cancer and aquaporin protein response to acetazolamide in hydrocephalus, to the genetics of stroke outcome and management of subarachnoid hemorrhage. True to his ever-curious spirit, his current projects are wide-ranging, including the utility of virtual shadowing as a force for equity in the pre-health pipeline, the development of new bioinformatic tools to monitor intracranial compliance, evaluating variability in the management of status epilepticus, and assessing the prevalence of self-fulfilling prophecy bias in neuroprognostication. He also serves as the site PI for the SENSE trial.

Dr. Ameli is the founding faculty member for the Medi-Gators Virtual Shadowing Program, with over 1500 participating pre-health students each semester. He regularly provides lectures to residents, fellows, and advanced practice providers in neurology, neurosurgery, emergency medicine, and critical care medicine. He also teaches UF’s medical students, providing multiple lectures during the MS2 Neuroscience block, MS3 Clerkship didactics, and MS4 Neurology elective.

Outside of work, Dr. Ameli loves to spend time with his wife, daughter, and dog. He loves afternoon walks with the family, exploring new restaurants, attempting to make all kinds of food at home (with a lot of help from his wife), and doing his best to stay active in the Florida sun. He is also a big sports fan with orange-and-blue running through his veins – Go Gators!


Presidential Citation
2021 · Neurocritical Care Society
Presidential Citation
2020 · Neurocritical Care Society
Invited Presenter
2019 · Society for Critical Care Medicine Teaching Competition
Future Leaders Form
2018 · Neurocritical Care Society
Founding Member, Center for Leadership and Service
2005-2007 · University of Florida

Board Certifications

  • Neurocritical Care
    American Board of Psychiatry and Neurology
  • Neurology
    American Board of Psychiatry and Neurology

Clinical Profile

  • Neurocritical Care
Areas of Interest
  • Stroke
  • Subarachnoid hemorrhage

Research Profile

Open Researcher and Contributor ID (ORCID)



5-Fluorouracil Neurotoxicity in the Absence of Dihydropyrimidine Dehydrogenase Deficiency Case Report.
The Neurohospitalist. 12(2):366-370 [DOI] 10.1177/19418744211068913. [PMID] 35419161.
Pregabalin for Recurrent Seizures in Critical Illness: A Promising Adjunctive Therapy, Especially for cyclic Seizures.
Neurocritical care. 37(1):140-148 [DOI] 10.1007/s12028-022-01459-6. [PMID] 35217998.
Evaluation and Management of Seizures and Status Epilepticus.
Neurologic clinics. 39(2):513-544 [DOI] 10.1016/j.ncl.2021.01.009. [PMID] 33896531.
The Modified Early Warning Score: A Useful Marker of Neurological Worsening but Unreliable Predictor of Sepsis in the Neurocritically Ill-A Retrospective Cohort Study.
Critical care explorations. 3(5) [DOI] 10.1097/CCE.0000000000000386. [PMID] 34036267.
Role of vasopressin and its antagonism in stroke related edema.
Journal of neuroscience research. 92(9):1091-9 [DOI] 10.1002/jnr.23407. [PMID] 24823792.
Visual-olfactory hallucinatory synesthesia: the Charles Bonnet Syndrome with olfactory hallucinations.
Cortex; a journal devoted to the study of the nervous system and behavior. 50:204-7 [DOI] 10.1016/j.cortex.2013.10.002. [PMID] 24290845.
Effect of acetazolamide on aquaporin-1 and fluid flow in cultured choroid plexus.
Acta neurochirurgica. Supplement. 113:59-64 [DOI] 10.1007/978-3-7091-0923-6_13. [PMID] 22116425.


Apr 2021 ACTIVE
A Prospective, Two-Stage, Non-randomized, Multi-center Within Patient Comparison Study to Evaluate the SENSE Devices Ability to Monitor Intracranial Hemorrhage
Role: Principal Investigator


Neurocritical Care Fellowship
2018-2020 · Emory University
Neurology Resident
2015-2018 · Vanderbilt University
Internship in Internal Medicine
2014-2015 · Vanderbilt University
2010-2014 · University of Central Florida College of Medicine
Masters of Science in Biotechnology
2008-2010 · University of Central Florida
BA in Philosophy
2003-2007 · University of Florida

Contact Details

(352) 273-5550
Business Mailing:
PO Box 100236
Business Street:
1149 NEWELL DR RM L3 100